CV:SVA Sernova Corp

Sernova Corp. is a clinical stage regenerative medicine company. It engages in the business of developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins and hormones missing within the body. The firm also focuses in the manufacture and clinical evaluation of the cell pouch for insulin-dependent diabetes. The company was founded in 1992 and is headquartered in London, Canada.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol SEOVF.

This company has cross-listed shares that trade in the U.S. as the symbol SEOVF.

1.57 CAD
As of 06/01/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Communication Services
Industry:  Medical Devices
Index country:  Canada
Country of incorporation:  Canada
IPO date:  01/01/1900
Stock exchange:    TSX Venture Exchange
Exchange country:   Canada
Market cap:   383,366,816 CAD
Current dividend yield:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy